- Home
- JNVR vs CPHI Comparison
JNVR vs CPHI Comparison
Compare JNVR & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JNVR
- CPHI
- Stock Information
- Founded
- JNVR 2018
- CPHI N/A
- Country
- JNVR United States
- CPHI China
- Employees
- JNVR N/A
- CPHI N/A
- Industry
- JNVR Finance: Consumer Services
- CPHI Biotechnology: Pharmaceutical Preparations
- Sector
- JNVR Finance
- CPHI Health Care
- Exchange
- JNVR Nasdaq
- CPHI Nasdaq
- Market Cap
- JNVR 5.4M
- CPHI 4.5M
- IPO Year
- JNVR 2023
- CPHI N/A
- Fundamental
- Price
- JNVR $5.00
- CPHI $0.25
- Analyst Decision
- JNVR
- CPHI
- Analyst Count
- JNVR 0
- CPHI 0
- Target Price
- JNVR N/A
- CPHI N/A
- AVG Volume (30 Days)
- JNVR 16.2K
- CPHI 635.8K
- Earning Date
- JNVR 03-13-2025
- CPHI 05-14-2025
- Dividend Yield
- JNVR N/A
- CPHI N/A
- EPS Growth
- JNVR N/A
- CPHI N/A
- EPS
- JNVR N/A
- CPHI N/A
- Revenue
- JNVR $2,099,660.00
- CPHI $4,528,929.00
- Revenue This Year
- JNVR N/A
- CPHI N/A
- Revenue Next Year
- JNVR N/A
- CPHI N/A
- P/E Ratio
- JNVR N/A
- CPHI N/A
- Revenue Growth
- JNVR 4.82
- CPHI N/A
- 52 Week Low
- JNVR $3.37
- CPHI $0.13
- 52 Week High
- JNVR $10.64
- CPHI $0.41
- Technical
- Relative Strength Index (RSI)
- JNVR 54.76
- CPHI 49.44
- Support Level
- JNVR $4.45
- CPHI $0.23
- Resistance Level
- JNVR $5.07
- CPHI $0.32
- Average True Range (ATR)
- JNVR 0.76
- CPHI 0.04
- MACD
- JNVR 0.10
- CPHI -0.00
- Stochastic Oscillator
- JNVR 41.83
- CPHI 25.00
About JNVR Janover Inc.
Janover Inc is a B2B fintech marketplace providing a platform for commercial property borrowers and lenders. It provides a technology platform that connects commercial mortgage borrowers looking for debt to refinance, build, or buy commercial property including apartment buildings to commercial property lenders including banks, credit unions, REITs, debt funds, and more looking to deploy capital into commercial mortgages. The firm caters to two consumer segments: lenders and borrowers. It derives the majority of its revenue from transaction fees.
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.